THE EVALUATION OF LONG-TERM RENOPROTECTIVE EFFECT OF CANDESARTAN, AN ANGIOTENSIN II RECEPTOR BLOCKER, IN CHRONIC RENAL DISEASES

被引：0
|
作者：
Shima, Yoshinori [1 ]
Satoh, Takeo [1 ]
Sakurada, Tsutomu [1 ]
Shirai, Sayuri [1 ]
Kuboshima, Shingo [1 ]
Yasuda, Takashi [1 ]
Kimura, Kenjiro [1 ]
机构：
[1] St Marianna Univ, Div Nephrol & Hypertens, Dept Internal Med, Sch Med, Kawasaki, Kanagawa, Japan
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A38 / A38
页数：1
相关论文
共 50 条
  • [1] Long-Term Renoprotective Effect of Candesartan in Renal Transplant Patients
    Ishii, T.
    Yasuda, M.
    Itami, Y.
    Hayashi, T.
    Uemura, H.
    Nose, K.
    Nishioka, T.
    [J]. TRANSPLANTATION PROCEEDINGS, 2012, 44 (03) : 638 - 641
  • [2] THE LONG-TERM BENEFIT OF ANGIOTENSIN II RECEPTOR BLOCKER
    Kang, Won Yu
    Kim, Wan
    Hwang, Sun Ho
    Kim, Kyung Hwan
    Cho, Sang Cheol
    Jeong, Myung Ho
    Ahn, Yeongkeun
    [J]. JOURNAL OF HYPERTENSION, 2016, 34 : E150 - E150
  • [3] Renoprotective effects of angiotensin II receptor blocker, candesartan cilexetil, in patients with stage 4–5 chronic kidney disease
    Yoshifuru Tamura
    Masahiro Kosuga
    Masahiro Yamashita
    Satoru Tomioka
    Michiko Sasaki
    Tomoyuki Hikita
    Hideaki Nakajima
    Kenichiro Kojima
    Shunya Uchida
    [J]. Clinical and Experimental Nephrology, 2008, 12 : 256 - 263
  • [4] Angiotensin II receptor blocker: Candesartan cilexetil
    Inada, Y
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 35P - 35P
  • [5] Candesartan cilexetil: An angiotensin II receptor blocker
    Stoukides, CA
    McVoy, HJ
    Kaul, AF
    [J]. ANNALS OF PHARMACOTHERAPY, 1999, 33 (12) : 1287 - 1298
  • [6] Renoprotective effect of angiotensin II receptor antagonists in experimental chronic renal failure
    Eliahou, H
    Avinoach, I
    Shahmurov, M
    Ben-David, A
    Shahar, C
    Matas, Z
    Zimlichman, R
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (01) : 78 - 83
  • [7] Renoprotective effects of angiotensin II receptor blocker, candesartan cilexetil, in patients with stage 4-5 chronic kidney disease
    Tamura, Yoshifuru
    Kosuga, Masahiro
    Yamashita, Masahiro
    Tomioka, Satoru
    Sasaki, Michiko
    Hikita, Tomoyuki
    Nakajima, Hideaki
    Kojima, Kenichiro
    Uchida, Shunya
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2008, 12 (04) : 256 - 263
  • [8] Short-term and long-term renoprotective effect with calcium channel blocker on top of either maximum or lower dose angiotensin receptor blocker in hypertensives
    Saito, F.
    Ichiyama, I.
    Harasawa, S.
    Onikura, M.
    Furuya, S.
    Ohkubo, K.
    Asai, T.
    Yoshizawa, T.
    Takase, H.
    Ishii, T.
    Ohiwa, K.
    Fujita, H.
    Takahashi, A.
    Takahashi, N.
    Hino, T.
    Ohtsuka, Y.
    Nishino, K.
    Uchiyama, T.
    Kanmatsuse, K.
    Kushiro, T.
    [J]. JOURNAL OF HYPERTENSION, 2006, 24 : S98 - S98
  • [9] Candesartan: widening indications for this angiotensin II receptor blocker?
    Mendis, B.
    Page, S. R.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (12) : 1995 - 2007
  • [10] Candesartan cilexetil: An angiotensin II-receptor blocker
    See, S
    Stirling, AL
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (08) : 739 - 746
12345